DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Ikesaka R, Siegal D, Mallick R. et al; Canadian Venous Thromboembolism Research Network (CanVECTOR).
Thromboprophylaxis with rivaroxaban in patients with malignancy and central venous lines (TRIM-Line): a two-center open-label pilot randomized controlled trial.
Res Pract Thromb Haemost 2021;
5 (04) e12517
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.